Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities

被引：0
|
作者：
Mario E. Lacouture
Milan J. Anadkat
René-Jean Bensadoun
Jane Bryce
Alexandre Chan
Joel B. Epstein
Beth Eaby-Sandy
Barbara A. Murphy
机构：
[1] Memorial Sloan–Kettering Cancer Center,Dermatology Service, Department of Medicine
[2] Washington University School of Medicine,undefined
[3] Centre Hospitalier Universitaire de Poitiers,undefined
[4] Istituto Nazionale dei Tumori,undefined
[5] National University of Singapore,undefined
[6] University of Illinois at Chicago,undefined
[7] University of Pennsylvania,undefined
[8] Vanderbilt University Medical Center,undefined
来源：
Supportive Care in Cancer | 2011年 / 19卷
关键词：
Rash; Xerosis; Paronychia; Pruritus; Radiation dermatitis; Mucositis; EGFR inhibitors; Recommendations;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1079 / 1095
页数：16
相关论文
共 50 条
  • [1] Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities
    Lacouture, Mario E.
    Anadkat, Milan J.
    Bensadoun, Rene-Jean
    Bryce, Jane
    Chan, Alexandre
    Epstein, Joel B.
    Eaby-Sandy, Beth
    Murphy, Barbara A.
    SUPPORTIVE CARE IN CANCER, 2011, 19 (08) : 1079 - 1095
  • [2] Prevention and treatment of FGFR inhibitor-associated toxicities
    Mahipal, Amit
    Tella, Sri Harsha
    Kommalapati, Anuhya
    Yu, James
    Kim, Richard
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 155
  • [3] Multidisciplinary Team-Working Indicators of Good Practice in the Clinical Management of EGFR-Inhibitor Dermatologic Toxicities
    Manganoni, Ausilia Maria
    Farisoglio, Camillo
    Ferrari, Vittorio
    Zaniboni, Alberto
    Beretta, Giordano
    Meriggi, Fausto
    Calzavara-Pinton, Piergiacomo
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (01) : 224 - 225
  • [4] Multidisciplinary Team-Working Indicators of Good Practice in the Clinical Management of EGFR-Inhibitor Dermatologic Toxicities
    Ausilia Maria Manganoni
    Camillo Farisoglio
    Vittorio Ferrari
    Alberto Zaniboni
    Giordano Beretta
    Fausto Meriggi
    Piergiacomo Calzavara-Pinton
    Annals of Surgical Oncology, 2009, 16 : 224 - 225
  • [5] mTOR inhibitor-associated dermatologic and mucosal problems
    Campistol, Josep M.
    de Fijter, Johan W.
    Flechner, Stuart M.
    Langone, Anthony
    Morelon, Emmanuel
    Stockfleth, Eggert
    CLINICAL TRANSPLANTATION, 2010, 24 (02) : 149 - 156
  • [6] Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicities
    Wu, Nan-Chun
    Feng, Yin-Hsun
    Kuo, Yu Hsuan
    Chen, Wei-Yu
    Wu, Hong-Chang
    Huang, Chien-Tai
    Wang, Wen-Ching
    Kang, Nai-Wen
    Shih, Jhih-Yuan
    Chen, Zhih-Cherng
    Chang, Wei-Ting
    ACTA CARDIOLOGICA SINICA, 2022, 38 (01) : 39 - 46
  • [7] EGFR Inhibitor-Associated Acneiform FolliculitisAssessment and Management
    Madeleine Duvic
    American Journal of Clinical Dermatology, 2008, 9 : 285 - 294
  • [8] Clinical practice guidelines for the treatment and prevention of cancer-associated thrombosis
    Lyman, Gary H.
    Kuderer, Nicole M.
    THROMBOSIS RESEARCH, 2020, 191 : S79 - S84
  • [9] Immune checkpoint inhibitor-associated cardiovascular toxicities: A review
    Liu, Guihong
    Chen, Tao
    Zhang, Xin
    Hu, Binbin
    Shi, Huashan
    HELIYON, 2024, 10 (05)
  • [10] Clinical and immunological analyses of immune checkpoint inhibitor-associated neuromuscular (NM) toxicities.
    Siddiqui, Bilal A.
    Durand, Jean-Bernard
    Gao, Jianjun
    Wang, Jianbo
    Aparicio, Ana
    Campbell, Matthew T.
    Siefker-Radtke, Arlene O.
    Tannir, Nizar M.
    Corn, Paul Gettys
    Msaouel, Pavlos
    Shah, Amishi Yogesh
    Zurita, Amado J.
    Tu, Shi-Ming
    Suarez-Almazor, Maria E.
    Sudhakar, Tummala
    Logothetis, Christopher
    Sharma, Padmanee
    Subudhi, Sumit Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345